|
US6127356A
(en)
|
1993-10-15 |
2000-10-03 |
Duke University |
Oxidant scavengers
|
|
US20050171198A1
(en)
*
|
1997-06-20 |
2005-08-04 |
Metaphore Pharmaceuticals, Inc. |
SODm therapy for treatment, prevention, inhibition and reversal of inflammatory disease
|
|
US20060270639A1
(en)
*
|
1997-06-20 |
2006-11-30 |
Daniela Salvemini |
Combinations of superoxide dismutase mimetics and nonsteroidal analgesic/anti-inflammatory drugs
|
|
US6214817B1
(en)
|
1997-06-20 |
2001-04-10 |
Monsanto Company |
Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity
|
|
DE69813898T2
(de)
|
1997-11-03 |
2004-03-11 |
Duke University |
Substituierte porphyrinen
|
|
ATE312103T1
(de)
*
|
1999-01-25 |
2005-12-15 |
Nat Jewish Med & Res Center |
Substituierte porphyrine und deren therapeutische verwendungen
|
|
ES2240101T3
(es)
|
1999-05-27 |
2005-10-16 |
Monsanto Company |
Biomateriales modificados con mimeticos de superoxido dismutasa.
|
|
US20030069281A1
(en)
*
|
2000-06-14 |
2003-04-10 |
Irwin Fridovich |
Tetrapyrroles
|
|
US20020072512A1
(en)
*
|
2000-12-08 |
2002-06-13 |
Metaphore Pharmaceuticals, Inc |
Method of preventing and treating HIV-mediated central nervous system damage
|
|
DE60235955D1
(de)
*
|
2001-01-05 |
2010-05-27 |
Metaphore Pharmaceuticals Inc |
Zusammensetzungen und verfahren zur erhöhung der zytokin-aktivität und zur behandlung der hypotension assoziiert mit der verabreichung von zytokinen
|
|
DK1392328T3
(da)
|
2001-01-19 |
2009-11-09 |
Nat Jewish Health |
Medikament til beskyttelse i radioterapi
|
|
AU2002236861A1
(en)
*
|
2001-01-26 |
2002-08-06 |
Metaphore Pharmaceuticals, Inc. |
Method of treatment of neurodegenerative disorders using pentaaza-macrocyclic ligand complexes
|
|
JP4369124B2
(ja)
*
|
2001-03-02 |
2009-11-18 |
メタファー・ファーマシューティカルズ・インコーポレイテッド |
金属錯体のクロマトグラフィー
|
|
US20040137638A1
(en)
|
2002-03-04 |
2004-07-15 |
Slomczynska Urszula J. |
Chromatography of metal complexes
|
|
EP1439842A4
(en)
*
|
2001-06-01 |
2009-09-02 |
Nat Jewish Med & Res Center |
OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE
|
|
US20040236519A1
(en)
*
|
2001-06-08 |
2004-11-25 |
Marshall Garland R. |
Libraries of confomationally constrained peptides, chiral azacrowns, and peptidomimetics and methods of making the same
|
|
CA2451602A1
(en)
*
|
2001-06-26 |
2003-01-03 |
Metaphore Pharmaceuticals, Inc. |
Combination therapy of an sodm and a corticosteroid for prevention and/or treatment of inflammatory disease
|
|
WO2003039561A1
(en)
*
|
2001-11-02 |
2003-05-15 |
Elan Corporation, Plc |
Pharmaceutical composition
|
|
DE60231246D1
(de)
*
|
2001-12-14 |
2009-04-02 |
Alcon Inc |
Superoxiddismutas-mimetika zur behandlung von augenerkrankungen
|
|
US6933275B2
(en)
*
|
2002-05-01 |
2005-08-23 |
The Board Of Trustees Of The Leland Stanford Junior University |
Protein kinase C peptides for use in withdrawal
|
|
WO2003103680A1
(en)
*
|
2002-06-07 |
2003-12-18 |
Duke University |
Substituted porphyrins
|
|
US20030232784A1
(en)
*
|
2002-06-14 |
2003-12-18 |
Benedict James J. |
Hyaluronic acid-associated superoxide dismutase mimics and their use in the treatment of joint pain
|
|
CA2397684A1
(en)
*
|
2002-08-12 |
2004-02-12 |
Michael P. Murphy |
Mitochondrially targeted antioxidants
|
|
JP5189242B2
(ja)
*
|
2002-09-23 |
2013-04-24 |
アルケルメス ファーマ アイルランド リミテッド |
乱用抵抗性の医薬組成物
|
|
MXPA05005240A
(es)
*
|
2002-12-06 |
2005-07-25 |
Alcon Inc |
Imitadores de la superoxido - dismutasa para el tratamiento de desordenes y enfermedades oculares.
|
|
MXPA05005937A
(es)
*
|
2002-12-06 |
2005-08-18 |
Alcon Inc |
Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
|
|
KR100648618B1
(ko)
*
|
2003-11-19 |
2006-11-23 |
주식회사 웰스킨 |
활성 산소 억제제
|
|
CN1889961A
(zh)
*
|
2003-12-11 |
2007-01-03 |
爱尔康公司 |
用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物
|
|
US8217166B2
(en)
*
|
2005-05-05 |
2012-07-10 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
US20120301403A1
(en)
|
2007-06-21 |
2012-11-29 |
Galera Therapeutics, Llc |
Polyethylene glycolated superoxide dismutase mimetics
|
|
WO2006069326A2
(en)
*
|
2004-12-21 |
2006-06-29 |
Metaphore Pharmaceuticals, Inc. |
Polyethylene glycolated superoxide dismutase mimetics
|
|
KR100724586B1
(ko)
|
2005-12-09 |
2007-06-04 |
세종대학교산학협력단 |
수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물
|
|
LT2056675T
(lt)
|
2006-10-12 |
2019-05-27 |
Galera Labs, Llc |
Burnos gleivinės mukozito gydymo būdai
|
|
WO2009065059A2
(en)
|
2007-11-14 |
2009-05-22 |
Kereos, Inc. |
Super-oxide dismutase mimetics
|
|
EP2859916B1
(en)
|
2008-05-22 |
2017-11-29 |
Galera Labs, LLC |
Combination of an antimitotic agent and a selective superoxide dismutase mimetic in antitumor therapy
|
|
DK2300003T3
(da)
|
2008-05-23 |
2014-05-26 |
Nat Jewish Health |
Forbindelser til anvendelse i behandling af skade forbundet med eksponering for en alkylerende art
|
|
CA3120505C
(en)
|
2011-09-26 |
2024-11-12 |
Galera Labs, Llc |
METHODS OF TREATING DISEASES
|
|
UA126788C2
(uk)
|
2015-08-11 |
2023-02-08 |
Ґалера Лебз, Елелсі |
Комплексні сполуки, що містять макроциклічне кільце пентаази, які мають пероральну біодоступність
|
|
MX393974B
(es)
|
2016-05-03 |
2025-03-24 |
Galera Labs Llc |
Terapia de combinacion para tratamiento de cancer.
|
|
JP7166634B2
(ja)
|
2016-09-01 |
2022-11-08 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニー |
ペンタアザ大環状環複合体およびアスコルビン酸化合物による組み合わせ癌療法
|
|
JP2020507598A
(ja)
|
2017-02-15 |
2020-03-12 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーＧａｌｅｒａ Ｌａｂｓ， Ｌｌｃ |
局所腸送達のためのペンタアザマクロ環錯体
|
|
EP3388082A1
(en)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Combination cancer immunotherapy with pentaaza macrocyclic ring complex
|
|
EA201992431A1
(ru)
|
2017-10-13 |
2020-03-13 |
ГАЛЕРА ЛЭБЗ, ЭлЭлСи |
Комбинированная иммунотерапия рака с использованием пента-аза-макроциклического кольцевого комплекса
|
|
AU2019215032A1
(en)
|
2018-01-31 |
2020-09-10 |
Board Of Regents Of The University Of Texas System |
Combination cancer therapy with pentaaza macrocyclic ring complex and platinum-based anticancer agent
|
|
CA3167087A1
(en)
*
|
2020-02-13 |
2021-08-19 |
Anantha Rajmohan MUTHUSAMY |
Solid state forms of avasopasem manganese and process for preparation thereof
|
|
WO2025024390A2
(en)
*
|
2023-07-21 |
2025-01-30 |
Galera Labs, Llc |
Carcinogenesis reduction with pentaaza macrocyclic ring complex
|